252 related articles for article (PubMed ID: 9741512)
1. Superiority of "triple" drug therapy in heart failure: insights from the PROVED and RADIANCE trials. Prospective Randomized Study of Ventricular Function and Efficacy of Digoxin. Randomized Assessment of Digoxin and Inhibitors of Angiotensin-Converting Enzyme.
Young JB; Gheorghiade M; Uretsky BF; Patterson JH; Adams KF
J Am Coll Cardiol; 1998 Sep; 32(3):686-92. PubMed ID: 9741512
[TBL] [Abstract][Full Text] [Related]
2. Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors. RADIANCE Study.
Packer M; Gheorghiade M; Young JB; Costantini PJ; Adams KF; Cody RJ; Smith LK; Van Voorhees L; Gourley LA; Jolly MK
N Engl J Med; 1993 Jul; 329(1):1-7. PubMed ID: 8505940
[TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of beta blockade in patients with chronic congestive heart failure awaiting transplantation.
Kalman J; Buchholz C; Steinmetz M; Courtney M; Gass A; Lansman S; Kukin ML
J Heart Lung Transplant; 1995; 14(6 Pt 1):1212-7. PubMed ID: 8719469
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin converting enzyme inhibition at rest and during exercise in congestive heart failure.
Kelbaek H; Agner E; Wroblewski H; Vasehus Madsen P; Marving J
Eur Heart J; 1993 May; 14(5):692-5. PubMed ID: 8508863
[TBL] [Abstract][Full Text] [Related]
5. Clinical benefits of low serum digoxin concentrations in heart failure.
Adams KF; Gheorghiade M; Uretsky BF; Patterson JH; Schwartz TA; Young JB
J Am Coll Cardiol; 2002 Mar; 39(6):946-53. PubMed ID: 11897434
[TBL] [Abstract][Full Text] [Related]
6. Can further benefit be achieved by adding flosequinan to patients with congestive heart failure who remain symptomatic on diuretic, digoxin, and an angiotensin converting enzyme inhibitor? Results of the flosequinan-ACE inhibitor trial (FACET).
Massie BM; Berk MR; Brozena SC; Elkayam U; Plehn JF; Kukin ML; Packer M; Murphy BE; Neuberg GW; Steingart RM
Circulation; 1993 Aug; 88(2):492-501. PubMed ID: 8339411
[TBL] [Abstract][Full Text] [Related]
7. Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: results of the PROVED trial. PROVED Investigative Group.
Uretsky BF; Young JB; Shahidi FE; Yellen LG; Harrison MC; Jolly MK
J Am Coll Cardiol; 1993 Oct; 22(4):955-62. PubMed ID: 8409069
[TBL] [Abstract][Full Text] [Related]
8. Cross-sectional study of heart failure therapy with angiotensin converting enzyme inhibitors and digoxin.
Mahmood SA; Hussein GM; Hamza EA
Saudi Med J; 2004 Aug; 25(8):1060-5. PubMed ID: 15322598
[TBL] [Abstract][Full Text] [Related]
9. Comparison of lisinopril versus digoxin for congestive heart failure during maintenance diuretic therapy. The Lisinopril-Digoxin Study Group.
Herlitz J
Am J Cardiol; 1992 Oct; 70(10):84C-90C. PubMed ID: 1329479
[TBL] [Abstract][Full Text] [Related]
10. Effects of increasing maintenance dose of digoxin on left ventricular function and neurohormones in patients with chronic heart failure treated with diuretics and angiotensin-converting enzyme inhibitors.
Gheorghiade M; Hall VB; Jacobsen G; Alam M; Rosman H; Goldstein S
Circulation; 1995 Oct; 92(7):1801-7. PubMed ID: 7671364
[TBL] [Abstract][Full Text] [Related]
11. A comparison of the efficacy and safety of ramipril and digoxin added to maintenance diuretic treatment in patients with chronic heart failure.
Kholeif MA; Pringle S; Kesson E; Murray G; Kennedy JA; Lorimer AR; Stock JK; Brown JJ
J Cardiovasc Pharmacol; 1991; 18 Suppl 2():S180-3. PubMed ID: 1725036
[TBL] [Abstract][Full Text] [Related]
12. Triple drug therapy--what is next?
Goldstein S
J Am Coll Cardiol; 1998 Sep; 32(3):693-4. PubMed ID: 9741513
[No Abstract] [Full Text] [Related]
13. Safety and tolerability of angiotensin-converting enzyme inhibitor versus the combination of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker in patients with left ventricular dysfunction: a systematic review and meta-analysis of randomized controlled trials.
Lakhdar R; Al-Mallah MH; Lanfear DE
J Card Fail; 2008 Apr; 14(3):181-8. PubMed ID: 18381180
[TBL] [Abstract][Full Text] [Related]
14. Patients with mild heart failure worsen during withdrawal from digoxin therapy.
Adams KF; Gheorghiade M; Uretsky BF; Young JB; Ahmed S; Tomasko L; Packer M
J Am Coll Cardiol; 1997 Jul; 30(1):42-8. PubMed ID: 9207619
[TBL] [Abstract][Full Text] [Related]
15. Clinical predictors of worsening heart failure during withdrawal from digoxin therapy.
Adams KF; Gheorghiade M; Uretsky BF; Young JB; Patterson JH; Tomasko L; Packer M
Am Heart J; 1998 Mar; 135(3):389-97. PubMed ID: 9506323
[TBL] [Abstract][Full Text] [Related]
16. Fosinopril attenuates clinical deterioration and improves exercise tolerance in patients with heart failure. Fosinopril Efficacy/Safety Trial (FEST) Study Group.
Erhardt L; MacLean A; Ilgenfritz J; Gelperin K; Blumenthal M
Eur Heart J; 1995 Dec; 16(12):1892-9. PubMed ID: 8682023
[TBL] [Abstract][Full Text] [Related]
17. Digoxin use in congestive heart failure. Current status.
Riaz K; Forker AD
Drugs; 1998 Jun; 55(6):747-58. PubMed ID: 9617590
[TBL] [Abstract][Full Text] [Related]
18. Study of Acute Kidney Injury on 309 Hypertensive Inpatients with ACEI/ARB - Diuretic Treatment.
Chen Q; Zhu S; Liao J; He W
J Natl Med Assoc; 2018 Jun; 110(3):287-296. PubMed ID: 29778133
[TBL] [Abstract][Full Text] [Related]
19. Digoxin for chronic heart failure: a review of the randomized controlled trials with special attention to the PROVED (Prospective Randomized Study of Ventricular Failure and the Efficacy of Digoxin) and RADIANCE (Randomized Assessment of Digoxin on Inhibitors of the angiotensin Converting Enzyme) trials.
Tauke J; Goldstein S; Gheorghiade M
Prog Cardiovasc Dis; 1994; 37(1):49-58. PubMed ID: 8022986
[No Abstract] [Full Text] [Related]
20. Review of randomized trials of digoxin therapy in patients with chronic heart failure.
Gheorghiade M; Zarowitz BJ
Am J Cardiol; 1992 Jun; 69(18):48G-62G; discussion 62G-63G. PubMed ID: 1626492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
